Results 201 to 210 of about 340,285 (357)

Evaluation of different methods of ischemic postconditioning preventing mesenteric reperfusion injury

, 2016
Carlos Henrique Marques dos SANTOS
openalex   +1 more source

Expression of Neuronal Nitric Oxide Synthase (nNOS) on Ischemia/reperfusion Injury in Rat Spinal Cord [PDF]

, 2007
Hee Uk Kwon, Kwang Ho Lee, Po Soon Kang, Choon Kyu Cho, Chun Woo Yang, Choon Mo Yang, Jong Taek Park   +6 more
openalex   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Ischemia Reperfusion Injury

JACC: Basic to Translational Science, 2023
Gonzalo Pizarro, MD, PhD
doaj   +1 more source

PANoptosis and mitochondrial regulatory mechanisms in cerebral ischemia-reperfusion injury. [PDF]

Front Physiol
Li L, Guo C, Zuo Z, Cai L, Chen X, Fang Y, Zhang S, Chen T, Kuang P, Zhang P, Li L, Wang Z.   +11 more
europepmc   +1 more source

Biochemical and Histopathologic Investigation of the Effect of Rilmenidine on Ovarian Ischemia-Reperfusion Injury in Rats [PDF]

Betül Kalkan Yılmaz, Seval Bulut, Nesrin Yilmaz, Nihal Yücel, Betül Çiçek, Berrin Göktuğ Kadıoğlu, Nuri Bakan, Ali Sefa Mendĭl, Halis Süleyman   +8 more
openalex   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Ketogenic Diet and Hepatic Ischaemia–Reperfusion Injury: Aggravation or Mitigation? [PDF]

Hanwen Yang, Yujun Zhao
openalex   +1 more source

Risk Factors and Clinical Outcomes of Brain Reperfusion Injury after Mechanical Thrombectomy for Ischemic Stroke

, 2021
Ji Hyun Moon, Hye-Ran Choi
openalex   +2 more sources

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li, Max Homilius, Erin Achilles, Laura K. Massey, Victoria Convey, Åsa Ohlsson, Ingrid Ljungvall, Jens Häggström, Brittany Vester Boler, Pascal Steiner, Sharlene Day, Calum A. MacRae, Mark A. Oyama   +12 more
wiley   +1 more source